Zoetis Inc - Ordinary Shares - Class A

NYSE:ZTS

150.19

+0.73 (+0.49%)

4:12:55 PM EDT: $150.14 -0.05 (-0.03%)

Market Cap (Intraday)	70.59B
Current PE	33.81
Forward PE	29.98
2yr Forward PE	26.54

See more stats

Estimates Current Quarter

Revenue	$2.1 Billion
Adjusted EPS	$1.28

See more estimates

10-Day MA	$154.73
50-Day MA	$167.45
200-Day MA	$184.32

See more pivots

Zoetis Inc - Ordinary Shares - Class A Stock, NYSE:ZTS

10 Sylvan Way, 10 Sylvan Way, Parsippany, New Jersey 07054

Phone: +1.973.822.7000

Number of Employees: 12100

http://www.zoetis.com

Description

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products, biodevices, genetic tests, and precision livestock farming technology. The firm operates through the following segments: United States & International. Its products include vaccines, parasiticides, anti-infectives, dermatology products, medicated feed additives, animal health diagnostics, and other pharmaceutical products for both companion animal and livestock customers. The company was founded in 1952 and is headquartered in Parsippany, NJ.